Cargando…
Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder
Autism spectrum disorder comprises several neurodevelopmental conditions presenting symptoms in social communication and restricted, repetitive behaviors. A major roadblock for drug development for autism is the lack of robust behavioral signatures predictive of clinical efficacy. To address this is...
Autores principales: | Brunner, Daniela, Kabitzke, Patricia, He, Dansha, Cox, Kimberly, Thiede, Lucinda, Hanania, Taleen, Sabath, Emily, Alexandrov, Vadim, Saxe, Michael, Peles, Elior, Mills, Alea, Spooren, Will, Ghosh, Anirvan, Feliciano, Pamela, Benedetti, Marta, Luo Clayton, Alice, Biemans, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537259/ https://www.ncbi.nlm.nih.gov/pubmed/26273832 http://dx.doi.org/10.1371/journal.pone.0134572 |
Ejemplares similares
-
Mouse model systems of autism spectrum disorder: Replicability and informatics signature
por: Kabitzke, Patricia, et al.
Publicado: (2020) -
Differential impacts of Cntnap2 heterozygosity and Cntnap2 null homozygosity on axon and myelinated fiber development in mouse
por: Cifuentes-Diaz, Carmen, et al.
Publicado: (2023) -
Highthroughtput analysis of behavior for drug discovery
por: Alexandrov, Vadim, et al.
Publicado: (2015) -
Rapid, Computer Vision-Enabled Murine Screening System Identifies Neuropharmacological Potential of Two New Mechanisms
por: Roberds, Steven L., et al.
Publicado: (2011) -
SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition
por: Hanson, Jesse E., et al.
Publicado: (2013)